Recombinant Human CLM9 (C-6His)

Description

EnkiLife provides the Recombinant Human CLM9 (C-6His) protein,aslo know as CMRF35-Like Molecule 9,CLM-9,CD300 Antigen-Like Family Member G,Triggering Receptor Expressed on Myeloid Cells 4,TREM-4,CD300g,CD300LG,CLM9,TREM4, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human CMRF35-Like Molecule 9 is produced by our Mammalian expression system and the target gene encoding Leu19-Arg247 is expressed with a 6His tag at the C-terminus.Accession:Q6UXG3. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:25.78 KDa. Background:CMRF35-Like Molecule 9 (CD300LG) is a single-pass type I membrane protein which belongs to the CD300 family. CD300LG has one Ig-like V-type domain which mediates binding to lymphocyte. CD300LG is highly expressed in heart, skeletal muscle and placenta. CD300LG acts as a receptor which may mediate L-selectin-dependent lymphocyte rollings. CD300LG also binds SELL in a calcium dependent manner and lymphocyte. CD300LG may play a important role in molecular traffic across the capillary endothelium.